• 1
    Eckel R, Grundy S, Zimmet P. The metabolic syndrome. Lancet 2005; 365: 41528
  • 2
    Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 273552
  • 3
    Grundy SM, Brewer HB, Cleeman JI et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 4338
  • 4
    Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 16405
  • 5
    Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998; 1: 15762
  • 6
    Parsons JK, Carter HB, Partin AW et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 2006; 91: 25628
  • 7
    Wing RR, West DS, Grady D et al. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol 2010; 184: 100510
  • 8
    Subak LL, Wing R, West DS et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009; 360: 48190
  • 9
    Vella VL, Jaffe W, Lidicker J et al. Prevalence of urinary symptoms in morbidly obese women and changes after bariatric surgery. J Reprod Med 2009; 54: 597602
  • 10
    Dahle SE, Chokkalingam AP, Gao YT et al. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2002; 168: 599604
  • 11
    Giovannucci E, Rimm EB, Chute CG et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994; 140: 9891002
  • 12
    Rohrmann S, Smitt E, Giuvanucci E, Platz EA. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2004; 159: 3907
  • 13
    Zhuang TN, Ly LP, Cumming RG, Handelsman DJ. Growth and development during early manhood as determinants of prostate size in later life. J Clin Endocrinol Metab 2005; 90: 605563
  • 14
    Zucchetto A, Tavani A, Dal Maso L et al. History of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obes (Lond) 2005; 29: 798803
  • 15
    Khoo J, Piantadosi C, Worthley S, Wittert GA. Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men. Int J Obes 2010; 34: 1396403
  • 16
    Wahrenberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ 2005; 330: 13634
  • 17
    Burke JP, Rhodes T, Jacobson DJ et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol 2006; 164: 416
  • 18
    Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 2001; 54: 93544
  • 19
    Gupta A, Gupta S, Pavuk M, Roehrborn CG. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 2006; 68: 1198205
  • 20
    Cinar A, Hall SA, Link CL et al. Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health Survey. BJU Int 2008; 101: 124756
  • 21
    Kim GW, Doo SW, Yang WJ, Song YS. Effects of obesity on prostate volume and lower urinary tract symptoms in Korean men. Korean J Urol 2010; 51: 3447
  • 22
    Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999; 8: 2936
  • 23
    Rohrmann S, De Marzo AM, Smit E et al. Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 2005; 62: 2733
  • 24
    Azadzoi KM, Tarkan T, Siroky MB, Krane RJ. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. J Urol 1999; 161: 162635
  • 25
    Kozlowski R, Kershen RT, Siroky MB, Krane RJ, Azadzoi KM. Chronic ischemia alters prostate structure and reactivity in rabbits. J Urol 2001; 165: 101926
  • 26
    Ponholzer A, Temml C, Obermayr RP et al. The association between lower urinary tract symptoms and renal function in men: a cross-sectional and 5-year longitudinal analysis. J Urol 2006; 175: 1398402
  • 27
    Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 2008; 53: 122835
  • 28
    Pasanisi F, Contaldo F, De Simone G et al. Benefits of sustained moderate weight loss in obesity. Nutr Metab Cardiovasc Dis 2001; 11: 4016
  • 29
    Laaksonen DE, Lakka H-M, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002; 25: 161218
  • 30
    Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg 2002; 184: 9S16S